Magnus Persson is listed as a director on 4 SEC Form D filings by 1 issuer between Sep 2013 and May 2017: Avalo Therapeutics, Inc. (Rockville, MD — biotechnology — 2013–2017; $130.6M reported sold to 156 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Eugene Bauer (4 shared filings), Isaac Blech (4 shared filings), John Kaiser (4 shared filings), Blake M. Paterson (2 shared filings), Federica F. O'Brien (2 shared filings) and 15 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Magnus. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Magnus Persson and found 7 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Magnus Persson" (OH) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.